Camille Sebaaly
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Camille Sebaaly
Camille Sebaaly is recorded as CFO at Sunshine Biopharma Inc. (SBFM). Sunshine Biopharma Inc. reported in an 8-K filed January 30, 2024 that Camille Sebaaly was appointed Chief Financial Officer and Secretary, effective January 25, 2024. The proxy statement of Sunshine Biopharma Inc. reports total compensation of $930,000 for Camille Sebaaly in fiscal 2022, including a base salary of $300,000. Disclosed compensation is on record for 2 fiscal years.
“At the meeting the following persons were elected to the following positions: Mr. Camille Sebaaly | Chief Financial Officer and Secretary”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Sunshine Biopharma Inc.
Other people whose current roles at this company are on record from its filings.
- Dr. Steve N. Slilaty CEO
- Mr. Camille Sebaaly CFO
- Marc Beaudoin COO
- Mr. Marc Beaudoin COO
- Andrew Telsey Board Member
- Dr. Andrew Keller Board Member
- Dr. Rabi Kiderchah Board Member
- JD Kish Board Member
- Mr. David Natan Board Member
- Rabi Kiderchah Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Sunshine Biopharma Inc. (SBFM) | Chief Financial Officer | $300,000 | $930,000 |
| 2021 | Sunshine Biopharma Inc. (SBFM) | Chief Financial Officer | $40,000 | $346,000 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.